Underdosing of skeletal muscle relaxants, sequela

This code indicates a long-term consequence or complication arising from the insufficient administration or absorption of skeletal muscle relaxants, which are also known as neuromuscular blocking agents. These agents are used to temporarily paralyze muscles, often during surgery or in critical care settings. A sequela implies that the acute underdosing event has passed, but its lasting effects are still present.

Apply this code when documenting a chronic condition or permanent impairment that is directly attributable to a past underdosing of a neuromuscular blocking agent. This might include persistent muscle weakness, respiratory compromise, or other neurological deficits that developed as a result of the inadequate medication. It is used when the patient is no longer experiencing the acute underdosing but is being treated for its residual effects.

• Always assign this code as a secondary diagnosis, following the code for the specific sequela (e.g., muscle weakness, respiratory failure).
• Ensure documentation clearly links the current condition to a historical underdosing event of a skeletal muscle relaxant.
• The "S" seventh character indicates sequela and should be used for conditions that are the late effects of the underdosing.